Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2024.3196
Abstract: Key Points Question Is fluorine-18 prostate-specific membrane antigen–1007 positron emission tomography/computed tomography (18F-PSMA-1007 PET/CT) superior to multiparametric magnetic resonance imaging (MRI) for the locoregional primary staging of intermediate-risk and high-risk prostate cancers before treatment? Findings… read more here.
Keywords: multiparametric mri; fluorine prostate; prostate; 1007 pet ... See more keywords
[18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients
Sign Up to like & getrecommendations! Published in 2025 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-025-07085-6
Abstract: We hypothesised that applying radiomics to [18F]PSMA-1007 PET/CT images could help distinguish Unspecific Bone Uptakes (UBUs) from bone metastases in prostate cancer (PCa) patients. We compared the performance of radiomic features to human visual interpretation.… read more here.
Keywords: psma 1007; 18f psma; prostate cancer; bone ... See more keywords
The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Nuclear Medicine"
DOI: 10.1007/s12149-025-02026-7
Abstract: This study aimed the role of volumetric and dissemination features of staging [18F]PSMA-1007 PET/CT in predicting progression‐free survival (PFS) in patients with prostate cancer (PCa) and their relationship with the main clinical data (ISUP grade… read more here.
Keywords: psma 1007; volumetric dissemination; 18f psma; psma ... See more keywords
The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone
Sign Up to like & getrecommendations! Published in 2024 at "British Journal of Cancer"
DOI: 10.1038/s41416-024-02934-x
Abstract: The diagnostic utility of prostate biopsy is limited for prostate cancer (PCa) in the prostate-specific antigen (PSA) grey zone. This study aims to evaluate the diagnostic performance of multiparametric magnetic resonance imaging (mpMRI) and prostate-specific… read more here.
Keywords: psma 1007; 18f psma; prostate; pet ... See more keywords
Diagnostic value of 18F-prostate-specific membrane antigen-1007 PET/MRI versus 18F-prostate-specific membrane antigen-1007 PET/computed tomography for biochemical recurrence of prostate cancer after radical prostatectomy
Sign Up to like & getrecommendations! Published in 2025 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000002028
Abstract: Objective To assess the diagnostic value of fluorine 18 (18F)-labeled prostate-specific membrane antigen (PSMA)-1007 PET/MRI and compare with that of 18F-PSMA-1007 PET/computed tomography (CT) for biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy.… read more here.
Keywords: pet mri; antigen; prostate specific; pet ... See more keywords
Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002354
Abstract: Prostate-specific membrane antigen (PSMA) is a membrane glycoprotein that is overexpressed in prostate cancer cells. It is also expressed in other normal tissues and several other malignant and benign diseases. We present a case of… read more here.
Keywords: psma 1007; prostate cancer; psma; 1007 pet ... See more keywords
Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004430
Abstract: Purpose This study aimed to compare 18F-PSMA-1007 PET/CT with 68Ga-PSMA-11 PET/CT for initial staging in intermediate- and high-risk prostate cancer (PCa) patients. Methods Forty treatment-naive, biopsy-proven, intermediate- or high-risk PCa patients were prospectively recruited. Each… read more here.
Keywords: pet; 68ga psma; psma; 1007 pet ... See more keywords
Hemangioma of the Ilium Simulating Bone Metastasis on 18F-PSMA-1007 PET/CT.
Sign Up to like & getrecommendations! Published in 2024 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000005076
Abstract: ABSTRACT A 64-year-old man was referred for 18F-PSMA-1007 PET/CT scan for initial staging of biopsy-proved prostate adenocarcinoma. 18F-PSMA-1007 PET/CT showed focal intense 18F-PSMA-1007 of the prostate adenocarcinoma and a focal intense activity with SUVmax of… read more here.
Keywords: psma 1007; 18f psma; psma; bone ... See more keywords
A comparative study of 18F-PSMA-1007 PET/CT and pelvic MRI in newly diagnosed prostate cancer
Sign Up to like & getrecommendations! Published in 2024 at "BMC Medical Imaging"
DOI: 10.1186/s12880-024-01376-4
Abstract: Purpose To evaluate the difference in the diagnostic efficacy of ^18F-PSMA-1007 PET/CT and pelvic MRI in primary prostate cancer, as well as the correlation between the two methods and histopathological parameters and serum PSA levels.… read more here.
Keywords: psma 1007; 18f psma; prostate; 1007 pet ... See more keywords
Synthesizing [18F]PSMA-1007 PET bone images from CT images with GAN for early detection of prostate cancer bone metastases: a pilot validation study
Sign Up to like & getrecommendations! Published in 2025 at "BMC Cancer"
DOI: 10.1186/s12885-025-14301-x
Abstract: [18F]FDG PET/CT scan combined with [18F]PSMA-1007 PET/CT scan is commonly conducted for detecting bone metastases in prostate cancer (PCa). However, it is expensive and may expose patients to more radiation hazards. This study explores deep… read more here.
Keywords: psma 1007; 18f psma; bone images; bone ... See more keywords
Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1018833
Abstract: Objective The aim of this study was to evaluate the performance of Fluoride-18 (18F)-PSMA-1007-PET/CT radiomics for the tumor malignancy and clinical risk stratification in primary prostate cancer (PCa). Materials and Methods A total of 161… read more here.
Keywords: psma 1007; pet; risk stratification; 1007 pet ... See more keywords